| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.04e-12 | 26 | 73 | 7 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 7.63e-10 | 52 | 73 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.11e-09 | 14 | 73 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 3.52e-08 | 26 | 73 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 ITPR2 | 4.51e-08 | 343 | 73 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 ITPR2 | 9.74e-08 | 459 | 73 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 ITPR2 | 4.12e-07 | 525 | 73 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 ITPR2 | 4.20e-07 | 526 | 73 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 ITPR2 | 9.41e-07 | 465 | 73 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.03e-06 | 171 | 73 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN11A ATP8A1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 ITPR2 | 4.75e-06 | 664 | 73 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SCN11A ATP8A1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 ITPR2 | 5.27e-06 | 793 | 73 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 1.32e-05 | 2 | 73 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 ITPR2 | 1.63e-05 | 627 | 73 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 ITPR2 | 1.80e-05 | 758 | 73 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.68e-05 | 18 | 73 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 7.87e-05 | 4 | 73 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 7.87e-05 | 4 | 73 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 7.87e-05 | 4 | 73 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | glutaminase activity | 7.87e-05 | 4 | 73 | 2 | GO:0004359 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN11A ABCA2 ATP8A1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 ITPR2 | 8.16e-05 | 1180 | 73 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.26e-04 | 70 | 73 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 1.31e-04 | 5 | 73 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 1.31e-04 | 5 | 73 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 1.31e-04 | 5 | 73 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 1.31e-04 | 5 | 73 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.96e-04 | 31 | 73 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.96e-04 | 6 | 73 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | transporter activity | SCN11A ABCA2 ATP8A1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 ITPR2 | 2.07e-04 | 1289 | 73 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.36e-04 | 33 | 73 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 7.10e-04 | 11 | 73 | 2 | GO:0180030 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.21e-04 | 118 | 73 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.39e-03 | 334 | 73 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | floppase activity | 1.53e-03 | 16 | 73 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.54e-03 | 230 | 73 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.73e-03 | 17 | 73 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.77e-03 | 614 | 73 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.94e-03 | 18 | 73 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 1.94e-03 | 18 | 73 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 3.26e-03 | 81 | 73 | 3 | GO:0016811 | |
| GeneOntologyMolecularFunction | cyclase activity | 3.45e-03 | 24 | 73 | 2 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 3.75e-03 | 25 | 73 | 2 | GO:0016849 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.69e-03 | 28 | 73 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 4.69e-03 | 28 | 73 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 5.48e-03 | 193 | 73 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | methyl-CpG binding | 5.72e-03 | 31 | 73 | 2 | GO:0008327 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.89e-03 | 197 | 73 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 6.47e-03 | 33 | 73 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.08e-03 | 37 | 73 | 2 | GO:0045505 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.39e-11 | 36 | 74 | 7 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 5.38e-11 | 62 | 74 | 8 | GO:0086002 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 8.67e-10 | 87 | 74 | 8 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.48e-09 | 93 | 74 | 8 | GO:0086003 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 2.70e-09 | 63 | 74 | 7 | GO:0019228 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 5.39e-09 | 217 | 74 | 10 | GO:0006941 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.77e-08 | 127 | 74 | 8 | GO:0070252 | |
| GeneOntologyBiologicalProcess | action potential | 4.24e-08 | 201 | 74 | 9 | GO:0001508 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 7.60e-08 | 153 | 74 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 1.49e-07 | 167 | 74 | 8 | GO:0060048 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.54e-07 | 112 | 74 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.61e-07 | 121 | 74 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A CTNNA3 SCN9A CKAP5 KCNIP1 OPRD1 GABRA1 | 6.63e-07 | 559 | 74 | 12 | GO:0042391 |
| GeneOntologyBiologicalProcess | muscle contraction | 1.60e-06 | 400 | 74 | 10 | GO:0006936 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 9.74e-06 | 208 | 74 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | circulatory system process | SCN11A ABCA2 ATP8A1 AVPR2 SCN1A SCN2A SCN3A SCN5A SCN8A CTNNA3 SCN9A FAAH | 1.08e-05 | 733 | 74 | 12 | GO:0003013 |
| GeneOntologyBiologicalProcess | heart contraction | 1.14e-05 | 298 | 74 | 8 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 1.48e-05 | 309 | 74 | 8 | GO:0003015 | |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | ACSL1 ABCA2 NADSYN1 GUCY2F PIGK PDHB UCKL1 PPIP5K1 PPIP5K2 ADCY9 MVD | 1.77e-05 | 644 | 74 | 11 | GO:0090407 |
| GeneOntologyBiologicalProcess | muscle system process | 2.48e-05 | 547 | 74 | 10 | GO:0003012 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 5.83e-05 | 275 | 74 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | blood circulation | SCN11A AVPR2 SCN1A SCN2A SCN3A SCN5A SCN8A CTNNA3 SCN9A FAAH | 1.03e-04 | 648 | 74 | 10 | GO:0008015 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN11A ATP8A1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 ITPR2 | 1.23e-04 | 942 | 74 | 12 | GO:0098655 |
| GeneOntologyBiologicalProcess | behavioral response to chemical pain | 1.26e-04 | 5 | 74 | 2 | GO:0061366 | |
| GeneOntologyBiologicalProcess | behavioral response to formalin induced pain | 1.26e-04 | 5 | 74 | 2 | GO:0061368 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN11A ATP8A1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 ITPR2 | 1.51e-04 | 1115 | 74 | 13 | GO:0034220 |
| GeneOntologyBiologicalProcess | behavioral response to pain | 2.04e-04 | 32 | 74 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 2.06e-04 | 81 | 74 | 4 | GO:0098900 | |
| GeneOntologyBiologicalProcess | metal ion transport | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 OPRD1 ITPR2 | 2.15e-04 | 1000 | 74 | 12 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN11A ATP8A1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 OPRD1 ITPR2 | 2.18e-04 | 1157 | 74 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 ITPR2 | 2.51e-04 | 1017 | 74 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | behavior | SCN11A ABCA2 ATP8A1 SCN1A SCN2A SCN3A SCN8A SCN9A CKAP5 DMBX1 OPRD1 | 3.18e-04 | 891 | 74 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN11A ATP8A1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 OPRD1 GABRA1 ITPR2 | 3.32e-04 | 1374 | 74 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 ITPR2 | 4.25e-04 | 922 | 74 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | central nervous system myelin formation | 4.50e-04 | 9 | 74 | 2 | GO:0032289 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 4.93e-04 | 43 | 74 | 3 | GO:0062149 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 5.47e-04 | 284 | 74 | 6 | GO:0007626 | |
| GeneOntologyBiologicalProcess | inositol metabolic process | 5.61e-04 | 10 | 74 | 2 | GO:0006020 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 6.84e-04 | 11 | 74 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | ACSL1 MTMR12 ABCA2 NADSYN1 GUCY2F PIGK PDHB UCKL1 PPIP5K1 PPIP5K2 ADCY9 MVD | 7.12e-04 | 1142 | 74 | 12 | GO:0019637 |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 8.07e-04 | 116 | 74 | 4 | GO:0008344 | |
| GeneOntologyBiologicalProcess | response to pain | 8.16e-04 | 51 | 74 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | nucleotide biosynthetic process | 1.00e-03 | 319 | 74 | 6 | GO:0009165 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate biosynthetic process | 1.02e-03 | 320 | 74 | 6 | GO:1901293 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.12e-03 | 14 | 74 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.13e-03 | 57 | 74 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | ACSL1 NCOA3 SCN5A ALAS1 KDM5D RYR1 RYR3 OPRD1 DNMT1 GABRA1 ITPR2 | 1.22e-03 | 1048 | 74 | 11 | GO:0014070 |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte communication | 1.29e-03 | 15 | 74 | 2 | GO:0086069 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.19e-13 | 17 | 76 | 7 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 9.26e-12 | 29 | 76 | 7 | GO:0034706 | |
| GeneOntologyCellularComponent | transporter complex | SHISA9 SCN11A ABCA2 ATP8A1 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 | 9.94e-09 | 550 | 76 | 14 | GO:1990351 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | SHISA9 SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 | 1.13e-08 | 378 | 76 | 12 | GO:0034702 |
| GeneOntologyCellularComponent | cation channel complex | 1.33e-08 | 235 | 76 | 10 | GO:0034703 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | SHISA9 SCN11A ABCA2 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 GABRA1 | 4.70e-08 | 523 | 76 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | plasma membrane protein complex | SHISA9 SCN11A ABCA2 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A C8B KCNIP1 RYR1 | 2.47e-05 | 785 | 76 | 12 | GO:0098797 |
| GeneOntologyCellularComponent | node of Ranvier | 5.04e-05 | 20 | 76 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | sarcoplasm | 5.99e-05 | 114 | 76 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | intercalated disc | 1.10e-04 | 68 | 76 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | axon initial segment | 1.58e-04 | 29 | 76 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DOCK1 SHISA9 KIF21B SCN11A ATP8A1 TRIO DROSHA SCN2A SCN8A ARFGEF2 FAAH | 1.71e-04 | 817 | 76 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | T-tubule | 1.97e-04 | 79 | 76 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | Z disc | 2.25e-04 | 151 | 76 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | membrane protein complex | SHISA9 SCN11A ABCA2 PIGK SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A C8B KCNIP1 RYR1 RYR3 GABRA1 | 2.79e-04 | 1498 | 76 | 15 | GO:0098796 |
| GeneOntologyCellularComponent | sarcomere | 2.93e-04 | 249 | 76 | 6 | GO:0030017 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.99e-04 | 88 | 76 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | I band | 3.49e-04 | 166 | 76 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | axon | KIF21B SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A ADCY9 OPRD1 ITPR2 | 3.60e-04 | 891 | 76 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | cell-cell contact zone | 3.84e-04 | 94 | 76 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | junctional membrane complex | 4.62e-04 | 9 | 76 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | myofibril | 4.78e-04 | 273 | 76 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 5.87e-04 | 45 | 76 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcolemma | 6.45e-04 | 190 | 76 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.56e-04 | 290 | 76 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | dynein complex | 1.00e-03 | 54 | 76 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF21B DNAL4 MTMR12 SCN1A SCN5A SCN8A CKAP5 ARFGEF2 DNAH9 RYR1 RYR3 DNAH1 | 1.07e-03 | 1179 | 76 | 12 | GO:0099512 |
| GeneOntologyCellularComponent | dendrite membrane | 1.11e-03 | 56 | 76 | 3 | GO:0032590 | |
| GeneOntologyCellularComponent | supramolecular polymer | KIF21B DNAL4 MTMR12 SCN1A SCN5A SCN8A CKAP5 ARFGEF2 DNAH9 RYR1 RYR3 DNAH1 | 1.13e-03 | 1187 | 76 | 12 | GO:0099081 |
| GeneOntologyCellularComponent | somatodendritic compartment | SHISA9 KIF21B SCN11A SCN1A SCN3A SCN8A CKAP5 ARFGEF2 KCNIP1 ADCY9 OPRD1 GABRA1 | 1.51e-03 | 1228 | 76 | 12 | GO:0036477 |
| GeneOntologyCellularComponent | microtubule associated complex | 2.83e-03 | 161 | 76 | 4 | GO:0005875 | |
| GeneOntologyCellularComponent | neuron projection membrane | 3.33e-03 | 82 | 76 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.38e-03 | 277 | 76 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.71e-03 | 25 | 76 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | dendrite | 3.85e-03 | 858 | 76 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 3.91e-03 | 860 | 76 | 9 | GO:0097447 | |
| GeneOntologyCellularComponent | main axon | 4.19e-03 | 89 | 76 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | synaptic membrane | 5.26e-03 | 583 | 76 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 6.21e-03 | 201 | 76 | 4 | GO:0099634 | |
| HumanPheno | Dysgenesis of the hippocampus | 4.71e-08 | 16 | 35 | 5 | HP:0025101 | |
| HumanPheno | Complex febrile seizure | 4.71e-08 | 16 | 35 | 5 | HP:0011172 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.28e-07 | 8 | 35 | 4 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.28e-07 | 8 | 35 | 4 | HP:0200048 | |
| HumanPheno | Focal hemiclonic seizure | 5.48e-07 | 25 | 35 | 5 | HP:0006813 | |
| HumanPheno | Limited neck range of motion | 5.96e-07 | 11 | 35 | 4 | HP:0000466 | |
| HumanPheno | Abnormal hippocampus morphology | 6.70e-07 | 48 | 35 | 6 | HP:0025100 | |
| HumanPheno | Abnormal morphology of the limbic system | 7.60e-07 | 49 | 35 | 6 | HP:0007343 | |
| HumanPheno | Epilepsia partialis continua | 8.89e-07 | 12 | 35 | 4 | HP:0012847 | |
| HumanPheno | Obsessive-compulsive trait | 2.35e-06 | 33 | 35 | 5 | HP:0008770 | |
| HumanPheno | Facial tics | 2.42e-06 | 15 | 35 | 4 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 2.42e-06 | 15 | 35 | 4 | HP:0007207 | |
| HumanPheno | Generalized clonic seizure | 2.74e-06 | 34 | 35 | 5 | HP:0011169 | |
| HumanPheno | Focal motor status epilepticus | 4.17e-06 | 17 | 35 | 4 | HP:0032663 | |
| HumanPheno | Visually-induced seizure | 5.34e-06 | 18 | 35 | 4 | HP:0020216 | |
| HumanPheno | Poor fine motor coordination | 5.90e-06 | 69 | 35 | 6 | HP:0007010 | |
| HumanPheno | Focal clonic seizure | 8.07e-06 | 42 | 35 | 5 | HP:0002266 | |
| HumanPheno | Reflex seizure | 1.25e-05 | 22 | 35 | 4 | HP:0020207 | |
| HumanPheno | Atypical absence seizure | 1.27e-05 | 46 | 35 | 5 | HP:0007270 | |
| HumanPheno | Clonic seizure | 1.51e-05 | 81 | 35 | 6 | HP:0020221 | |
| HumanPheno | Tibial torsion | 1.51e-05 | 23 | 35 | 4 | HP:0100694 | |
| HumanPheno | Focal impaired awareness seizure | 1.81e-05 | 126 | 35 | 7 | HP:0002384 | |
| HumanPheno | Aggressive behavior | MKRN3 ABCA2 TRIO CEP85L RBL2 SCN1A SCN2A SCN3A SCN8A SCN9A TRAPPC10 DNMT1 GABRA1 | 1.84e-05 | 516 | 35 | 13 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | MKRN3 ABCA2 TRIO CEP85L RBL2 SCN1A SCN2A SCN3A SCN8A SCN9A TRAPPC10 DNMT1 GABRA1 | 1.84e-05 | 516 | 35 | 13 | HP:0006919 |
| HumanPheno | Poor motor coordination | 1.99e-05 | 85 | 35 | 6 | HP:0002275 | |
| HumanPheno | Limited knee extension | 2.93e-05 | 27 | 35 | 4 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 2.93e-05 | 27 | 35 | 4 | HP:0031475 | |
| HumanPheno | Simple febrile seizure | 2.93e-05 | 27 | 35 | 4 | HP:0011171 | |
| HumanPheno | Focal aware seizure | 3.40e-05 | 28 | 35 | 4 | HP:0002349 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 3.93e-05 | 29 | 35 | 4 | HP:0032658 | |
| HumanPheno | Progressive gait ataxia | 4.51e-05 | 30 | 35 | 4 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 4.51e-05 | 30 | 35 | 4 | HP:0001329 | |
| HumanPheno | Infection-related seizure | 4.51e-05 | 145 | 35 | 7 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 4.51e-05 | 145 | 35 | 7 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 4.51e-05 | 145 | 35 | 7 | HP:0002373 | |
| HumanPheno | Impulsivity | 5.38e-05 | 149 | 35 | 7 | HP:0100710 | |
| HumanPheno | Cogwheel rigidity | 5.86e-05 | 32 | 35 | 4 | HP:0002396 | |
| HumanPheno | Focal automatism seizure | 6.27e-05 | 12 | 35 | 3 | HP:0032898 | |
| HumanPheno | Generalized tonic seizure | 6.49e-05 | 64 | 35 | 5 | HP:0010818 | |
| HumanPheno | Multifocal epileptiform discharges | 7.53e-05 | 66 | 35 | 5 | HP:0010841 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 8.11e-05 | 13 | 35 | 3 | HP:0007058 | |
| HumanPheno | Limitation of knee mobility | 8.41e-05 | 35 | 35 | 4 | HP:0010501 | |
| HumanPheno | Limitation of neck motion | 9.41e-05 | 36 | 35 | 4 | HP:0005986 | |
| HumanPheno | Abnormal neck physiology | 9.41e-05 | 36 | 35 | 4 | HP:0025669 | |
| HumanPheno | Disturbance of facial expression | 9.41e-05 | 36 | 35 | 4 | HP:0005324 | |
| HumanPheno | Atypical absence status epilepticus | 1.89e-04 | 17 | 35 | 3 | HP:0011151 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 2.26e-04 | 18 | 35 | 3 | HP:0032860 | |
| HumanPheno | Focal motor seizure | 2.27e-04 | 131 | 35 | 6 | HP:0011153 | |
| HumanPheno | Abnormal knee physiology | 2.81e-04 | 87 | 35 | 5 | HP:0034670 | |
| HumanPheno | EEG with spike-wave complexes | 2.96e-04 | 88 | 35 | 5 | HP:0010850 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 3.13e-04 | 20 | 35 | 3 | HP:0032671 | |
| HumanPheno | Tonic seizure | 3.26e-04 | 140 | 35 | 6 | HP:0032792 | |
| HumanPheno | Talipes valgus | 3.63e-04 | 21 | 35 | 3 | HP:0004684 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 4.00e-04 | 52 | 35 | 4 | HP:0007334 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 4.00e-04 | 52 | 35 | 4 | HP:0025190 | |
| HumanPheno | Atonic seizure | 4.03e-04 | 94 | 35 | 5 | HP:0010819 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 4.53e-04 | 5 | 35 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 4.53e-04 | 5 | 35 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 4.53e-04 | 5 | 35 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 4.53e-04 | 5 | 35 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 4.53e-04 | 5 | 35 | 2 | HP:0032906 | |
| HumanPheno | Allodynia | 4.53e-04 | 5 | 35 | 2 | HP:0012533 | |
| HumanPheno | Rigidity | 5.15e-04 | 214 | 35 | 7 | HP:0002063 | |
| HumanPheno | Pes valgus | 5.33e-04 | 56 | 35 | 4 | HP:0008081 | |
| HumanPheno | Intellectual disability, borderline | 6.16e-04 | 25 | 35 | 3 | HP:0006889 | |
| HumanPheno | Compulsive behaviors | 6.23e-04 | 158 | 35 | 6 | HP:0000722 | |
| HumanPheno | Normal interictal EEG | 6.76e-04 | 6 | 35 | 2 | HP:0002372 | |
| HumanPheno | Abnormality of pain sensation | 9.38e-04 | 113 | 35 | 5 | HP:0010832 | |
| HumanPheno | Eyelid myoclonia seizure | 9.43e-04 | 7 | 35 | 2 | HP:0032678 | |
| HumanPheno | Pain insensitivity | 9.61e-04 | 29 | 35 | 3 | HP:0007021 | |
| HumanPheno | Limb myoclonus | 9.61e-04 | 29 | 35 | 3 | HP:0045084 | |
| HumanPheno | Cyanosis | 1.10e-03 | 117 | 35 | 5 | HP:0000961 | |
| HumanPheno | Generalized non-motor (absence) seizure | 1.10e-03 | 176 | 35 | 6 | HP:0002121 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.14e-03 | 118 | 35 | 5 | HP:0011185 | |
| HumanPheno | Epileptic encephalopathy | 1.18e-03 | 119 | 35 | 5 | HP:0200134 | |
| HumanPheno | Abnormal nasal mucus secretion | 1.25e-03 | 8 | 35 | 2 | HP:0031416 | |
| HumanPheno | Rhinorrhea | 1.25e-03 | 8 | 35 | 2 | HP:0031417 | |
| HumanPheno | Dialeptic seizure | 1.33e-03 | 251 | 35 | 7 | HP:0011146 | |
| HumanPheno | Calcaneovalgus deformity | 1.54e-03 | 34 | 35 | 3 | HP:0001848 | |
| HumanPheno | Abnormal social development | MKRN3 ABCA2 TRIO CEP85L RBL2 SCN1A SCN2A SCN3A SCN8A SCN9A ARFGEF2 TRAPPC10 DNMT1 GABRA1 | 1.67e-03 | 908 | 35 | 14 | HP:0025732 |
| HumanPheno | Deformed tarsal bones | 1.67e-03 | 35 | 35 | 3 | HP:0008119 | |
| HumanPheno | Myoclonic seizure | 1.71e-03 | 262 | 35 | 7 | HP:0032794 | |
| HumanPheno | Gait ataxia | 1.75e-03 | 263 | 35 | 7 | HP:0002066 | |
| HumanPheno | Disinhibition | MKRN3 ABCA2 TRIO CEP85L RBL2 SCN1A SCN2A SCN3A SCN8A SCN9A TRAPPC10 DNMT1 GABRA1 | 1.77e-03 | 807 | 35 | 13 | HP:0000734 |
| HumanPheno | Inappropriate behavior | MKRN3 ABCA2 TRIO CEP85L RBL2 SCN1A SCN2A SCN3A SCN8A SCN9A TRAPPC10 DNMT1 GABRA1 | 1.77e-03 | 807 | 35 | 13 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | MKRN3 ABCA2 TRIO CEP85L RBL2 SCN1A SCN2A SCN3A SCN8A SCN9A TRAPPC10 DNMT1 GABRA1 | 1.77e-03 | 807 | 35 | 13 | HP:5200123 |
| HumanPheno | Social disinhibition | MKRN3 ABCA2 TRIO CEP85L RBL2 SCN1A SCN2A SCN3A SCN8A SCN9A TRAPPC10 DNMT1 GABRA1 | 1.77e-03 | 807 | 35 | 13 | HP:5200029 |
| HumanPheno | Focal-onset seizure | 1.94e-03 | 346 | 35 | 8 | HP:0007359 | |
| HumanPheno | Non-motor seizure | 1.97e-03 | 197 | 35 | 6 | HP:0033259 | |
| HumanPheno | Sudden unexpected death in epilepsy | 1.99e-03 | 10 | 35 | 2 | HP:0033258 | |
| HumanPheno | Erythromelalgia | 1.99e-03 | 10 | 35 | 2 | HP:0032147 | |
| HumanPheno | Delirium | 1.99e-03 | 10 | 35 | 2 | HP:0031258 | |
| HumanPheno | EEG with generalized epileptiform discharges | 2.03e-03 | 270 | 35 | 7 | HP:0011198 | |
| HumanPheno | Neonatal seizure | 2.43e-03 | 11 | 35 | 2 | HP:0032807 | |
| HumanPheno | Impaired pain sensation | 2.44e-03 | 84 | 35 | 4 | HP:0007328 | |
| HumanPheno | Focal non-motor seizure | 2.47e-03 | 40 | 35 | 3 | HP:0032679 | |
| HumanPheno | Status epilepticus | 2.53e-03 | 207 | 35 | 6 | HP:0002133 | |
| MousePheno | abnormal action potential | 2.14e-06 | 133 | 63 | 7 | MP:0005402 | |
| MousePheno | abnormal nervous system electrophysiology | 1.54e-05 | 329 | 63 | 9 | MP:0002272 | |
| Domain | Na_channel_asu | 1.50e-15 | 10 | 75 | 7 | IPR001696 | |
| Domain | Na_trans_assoc | 1.50e-15 | 10 | 75 | 7 | IPR010526 | |
| Domain | Na_trans_assoc | 1.50e-15 | 10 | 75 | 7 | PF06512 | |
| Domain | Na_trans_cytopl | 3.42e-15 | 6 | 75 | 6 | PF11933 | |
| Domain | Na_trans_cytopl | 3.42e-15 | 6 | 75 | 6 | IPR024583 | |
| Domain | Ion_trans_dom | 2.86e-11 | 114 | 75 | 10 | IPR005821 | |
| Domain | Ion_trans | 2.86e-11 | 114 | 75 | 10 | PF00520 | |
| Domain | Channel_four-helix_dom | 2.85e-09 | 57 | 75 | 7 | IPR027359 | |
| Domain | - | 2.85e-09 | 57 | 75 | 7 | 1.20.120.350 | |
| Domain | IQ | 8.75e-07 | 81 | 75 | 6 | SM00015 | |
| Domain | RIH_assoc | 1.23e-06 | 6 | 75 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 1.23e-06 | 6 | 75 | 3 | IPR013662 | |
| Domain | RIH_dom | 1.23e-06 | 6 | 75 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.23e-06 | 6 | 75 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.23e-06 | 6 | 75 | 3 | IPR015925 | |
| Domain | - | 1.23e-06 | 6 | 75 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.23e-06 | 6 | 75 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 1.23e-06 | 6 | 75 | 3 | PF08709 | |
| Domain | IQ_motif_EF-hand-BS | 1.63e-06 | 90 | 75 | 6 | IPR000048 | |
| Domain | IQ | 1.98e-06 | 93 | 75 | 6 | PS50096 | |
| Domain | MIR | 7.31e-06 | 10 | 75 | 3 | PS50919 | |
| Domain | MIR | 7.31e-06 | 10 | 75 | 3 | PF02815 | |
| Domain | MIR | 7.31e-06 | 10 | 75 | 3 | SM00472 | |
| Domain | MIR_motif | 7.31e-06 | 10 | 75 | 3 | IPR016093 | |
| Domain | EF-hand-dom_pair | 1.95e-05 | 287 | 75 | 8 | IPR011992 | |
| Domain | Ryanrecept_TM4-6 | 4.76e-05 | 3 | 75 | 2 | IPR009460 | |
| Domain | RyR | 4.76e-05 | 3 | 75 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 4.76e-05 | 3 | 75 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 4.76e-05 | 3 | 75 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.76e-05 | 3 | 75 | 2 | IPR013333 | |
| Domain | ARM-type_fold | 6.35e-05 | 339 | 75 | 8 | IPR016024 | |
| Domain | IQ | 1.90e-04 | 71 | 75 | 4 | PF00612 | |
| Domain | Acid_Pase_AS | 2.36e-04 | 6 | 75 | 2 | IPR033379 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 3.30e-04 | 7 | 75 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 3.30e-04 | 7 | 75 | 2 | PS00616 | |
| Domain | EF-hand_8 | 3.40e-04 | 34 | 75 | 3 | PF13833 | |
| Domain | His_Pase_clade-2 | 4.39e-04 | 8 | 75 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 4.39e-04 | 8 | 75 | 2 | PF00328 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.40e-03 | 14 | 75 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.40e-03 | 14 | 75 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.40e-03 | 14 | 75 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.40e-03 | 14 | 75 | 2 | PF08393 | |
| Domain | MT | 1.40e-03 | 14 | 75 | 2 | PF12777 | |
| Domain | AAA_8 | 1.40e-03 | 14 | 75 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.40e-03 | 14 | 75 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.40e-03 | 14 | 75 | 2 | PF07728 | |
| Domain | DHC_fam | 1.62e-03 | 15 | 75 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.62e-03 | 15 | 75 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.62e-03 | 15 | 75 | 2 | PF03028 | |
| Domain | A/G_cyclase_CS | 2.08e-03 | 17 | 75 | 2 | IPR018297 | |
| Domain | Nucleotide_cyclase | 2.34e-03 | 18 | 75 | 2 | IPR029787 | |
| Domain | - | 2.34e-03 | 18 | 75 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 2.60e-03 | 19 | 75 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 2.60e-03 | 19 | 75 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 2.60e-03 | 19 | 75 | 2 | PS50125 | |
| Domain | A/G_cyclase | 2.60e-03 | 19 | 75 | 2 | IPR001054 | |
| Domain | CYCc | 2.60e-03 | 19 | 75 | 2 | SM00044 | |
| Domain | His_PPase_superfam | 2.88e-03 | 20 | 75 | 2 | IPR029033 | |
| Domain | - | 2.88e-03 | 20 | 75 | 2 | 3.40.50.1240 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 ITPR2 | 2.22e-11 | 130 | 67 | 11 | M27454 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 9.54e-11 | 31 | 67 | 7 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.22e-10 | 32 | 67 | 7 | M27455 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | SCN11A SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A KCNIP1 RYR1 RYR3 ITPR2 | 2.68e-09 | 203 | 67 | 11 | M5485 |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | SCN11A NADSYN1 GLS2 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A FAAH DNMT1 GABRA1 | 1.34e-07 | 367 | 67 | 12 | M48346 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.64e-06 | 121 | 67 | 7 | M872 | |
| Pathway | WP_DRAVET_SYNDROME | 8.76e-06 | 28 | 67 | 4 | M45519 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 9.42e-05 | 19 | 67 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.77e-04 | 27 | 67 | 3 | M47755 | |
| Pubmed | 7.07e-18 | 9 | 77 | 7 | 16382098 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 4.66e-14 | 5 | 77 | 5 | 22875929 | |
| Pubmed | 1.64e-13 | 13 | 77 | 6 | 15123669 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 2.79e-13 | 6 | 77 | 5 | 23652591 | |
| Pubmed | 5.83e-12 | 9 | 77 | 5 | 15746173 | ||
| Pubmed | 2.22e-11 | 4 | 77 | 4 | 17537961 | ||
| Pubmed | 2.22e-11 | 4 | 77 | 4 | 35031483 | ||
| Pubmed | 2.22e-11 | 4 | 77 | 4 | 29578003 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 3.65e-11 | 12 | 77 | 5 | 30175250 | |
| Pubmed | 1.11e-10 | 5 | 77 | 4 | 8812438 | ||
| Pubmed | 1.11e-10 | 5 | 77 | 4 | 17724025 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 19284629 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 12610651 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 33895391 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 23859570 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18784617 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17544618 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 32845893 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 28518218 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17928448 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 14973256 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 15302875 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.66e-08 | 139 | 77 | 7 | 16985003 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 21156207 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 4.17e-08 | 4 | 77 | 3 | 8974318 | |
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 1679748 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 24337656 | ||
| Pubmed | MKRN3 FRY ABCA2 ZBTB38 TRIO PDHB CEP85L DROSHA RBL2 CKAP5 PPP1R16B ARFGEF2 LDB2 RYR3 DNMT1 | 1.24e-07 | 1285 | 77 | 15 | 35914814 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 16029194 | ||
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 23463619 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 2.08e-07 | 6 | 77 | 3 | 17513486 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.08e-07 | 6 | 77 | 3 | 25966694 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 23711479 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.08e-07 | 6 | 77 | 3 | 16844763 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.63e-07 | 7 | 77 | 3 | 25818041 | |
| Pubmed | 3.63e-07 | 7 | 77 | 3 | 15272007 | ||
| Pubmed | 3.63e-07 | 7 | 77 | 3 | 11860456 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 3.63e-07 | 7 | 77 | 3 | 24440715 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 5.80e-07 | 8 | 77 | 3 | 19033399 | |
| Pubmed | 5.80e-07 | 8 | 77 | 3 | 25101983 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 8.68e-07 | 9 | 77 | 3 | 17884088 | |
| Pubmed | 2.26e-06 | 12 | 77 | 3 | 8169823 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 4.66e-06 | 15 | 77 | 3 | 9726281 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29649454 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 4.84e-06 | 2 | 77 | 2 | 37901435 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 4.84e-06 | 2 | 77 | 2 | 26410685 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18981179 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 4.84e-06 | 2 | 77 | 2 | 10827969 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19694741 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 4.84e-06 | 2 | 77 | 2 | 11245985 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26861708 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15760941 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12565913 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9489997 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9192302 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 4.84e-06 | 2 | 77 | 2 | 1317301 | |
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 4.84e-06 | 2 | 77 | 2 | 12640042 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 4.84e-06 | 2 | 77 | 2 | 23016767 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 27153334 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 33096315 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 4.84e-06 | 2 | 77 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 4.84e-06 | 2 | 77 | 2 | 25172946 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31439038 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 7556644 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 14592949 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22010048 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17702752 | ||
| Pubmed | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. | 4.84e-06 | 2 | 77 | 2 | 16054936 | |
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 4.84e-06 | 2 | 77 | 2 | 17805013 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 33712547 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 4.84e-06 | 2 | 77 | 2 | 15894801 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26311622 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 33411788 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31943325 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 4.84e-06 | 2 | 77 | 2 | 15249644 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 27690330 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9799464 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21789893 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9817784 | ||
| Pubmed | Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels. | 4.84e-06 | 2 | 77 | 2 | 32601768 | |
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 4.84e-06 | 2 | 77 | 2 | 27174182 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21377452 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28126903 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18601978 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21263457 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 4.84e-06 | 2 | 77 | 2 | 23965409 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 27245092 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 4.84e-06 | 2 | 77 | 2 | 19465131 | |
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 4.84e-06 | 2 | 77 | 2 | 16847056 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24719102 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20071580 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 4.84e-06 | 2 | 77 | 2 | 37665666 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17690096 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17881658 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 4.84e-06 | 2 | 77 | 2 | 17118445 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 30693367 | ||
| Interaction | SCN11A interactions | 1.70e-09 | 15 | 74 | 5 | int:SCN11A | |
| Interaction | SCN5A interactions | 1.90e-08 | 47 | 74 | 6 | int:SCN5A | |
| Interaction | CACNA1D interactions | 2.34e-08 | 24 | 74 | 5 | int:CACNA1D | |
| Interaction | NALCN interactions | 1.63e-07 | 14 | 74 | 4 | int:NALCN | |
| Interaction | MYPN interactions | 3.46e-07 | 40 | 74 | 5 | int:MYPN | |
| Interaction | SCN9A interactions | 9.56e-07 | 21 | 74 | 4 | int:SCN9A | |
| Interaction | SCN4B interactions | 2.63e-06 | 8 | 74 | 3 | int:SCN4B | |
| Interaction | SCN1A interactions | 3.71e-06 | 29 | 74 | 4 | int:SCN1A | |
| Interaction | CACNA1A interactions | 6.03e-06 | 123 | 74 | 6 | int:CACNA1A | |
| Interaction | SCN10A interactions | 7.68e-06 | 11 | 74 | 3 | int:SCN10A | |
| Interaction | CACNA1B interactions | 1.01e-05 | 37 | 74 | 4 | int:CACNA1B | |
| Interaction | YWHAH interactions | KIF21B FAM171A1 NCOA3 MTMR12 ABCA2 TRIO CEP85L CKAP5 TRAPPC10 MCM2 PPIP5K2 VIRMA TESPA1 DNMT1 | 4.13e-05 | 1102 | 74 | 14 | int:YWHAH |
| Interaction | SCN8A interactions | 5.18e-05 | 20 | 74 | 3 | int:SCN8A | |
| Interaction | CACNA1C interactions | 7.46e-05 | 61 | 74 | 4 | int:CACNA1C | |
| Interaction | PIK3C2G interactions | 7.94e-05 | 4 | 74 | 2 | int:PIK3C2G | |
| Interaction | ANTKMT interactions | 1.16e-04 | 26 | 74 | 3 | int:ANTKMT | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.52e-06 | 127 | 77 | 5 | chr2q24 | |
| Cytoband | 2q24 | 1.51e-04 | 11 | 77 | 2 | 2q24 | |
| Cytoband | 2q24.3 | 3.28e-04 | 16 | 77 | 2 | 2q24.3 | |
| Cytoband | 5p13.3 | 7.48e-04 | 24 | 77 | 2 | 5p13.3 | |
| Cytoband | 5p15.1 | 1.42e-03 | 33 | 77 | 2 | 5p15.1 | |
| Cytoband | 3p21.1 | 2.29e-03 | 42 | 77 | 2 | 3p21.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.32e-17 | 9 | 51 | 7 | 1203 | |
| GeneFamily | Dyneins, axonemal | 1.40e-05 | 17 | 51 | 3 | 536 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.34e-05 | 3 | 51 | 2 | 287 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | KIF21B FRY ZBTB38 SCN1A SCN2A SCN3A SCN8A CTNNA3 SCN9A CHN1 WDFY4 GABRA1 | 7.03e-07 | 703 | 75 | 12 | M39070 |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP | 1.37e-05 | 274 | 75 | 7 | M2348 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | EBF2 KIF21B FRY ZBTB38 ATP8A1 CEP85L SCN1A SCN2A SCN3A SCN8A SCN9A CHN1 GABRA1 | 1.39e-05 | 1106 | 75 | 13 | M39071 |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP | 1.47e-05 | 277 | 75 | 7 | MM917 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_500 | 1.54e-06 | 25 | 73 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_500 | |
| CoexpressionAtlas | BM Top 100 - parietal lobe | 5.98e-06 | 75 | 73 | 5 | BM Top 100 - parietal lobe | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.54e-05 | 91 | 73 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 7.68e-05 | 206 | 73 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | cerebral cortex | MKRN3 SHISA9 KIF21B ABCA2 SCN1A SCN2A SCN3A SCN8A CTNNA3 PPP1R16B LHX5 CHN1 KCNIP1 OPRD1 GABRA1 | 8.64e-05 | 1428 | 73 | 15 | cerebral cortex |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.77e-05 | 211 | 73 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| CoexpressionAtlas | BM Top 100 - cerebral cortex | 1.11e-04 | 72 | 73 | 4 | BM Top 100 - cerebral cortex | |
| CoexpressionAtlas | BM Top 100 - occipital lobe | 1.17e-04 | 73 | 73 | 4 | BM Top 100 - occipital lobe | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Sp, TCRbeta+ aGalCer tet+ CD4-, Spleen, avg-3 | 1.42e-04 | 331 | 73 | 7 | GSM538329_500 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.98e-04 | 245 | 73 | 6 | gudmap_kidney_adult_GlomCapSys_Tie2_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.01e-04 | 84 | 73 | 4 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k5 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4 | 2.03e-04 | 351 | 73 | 7 | GSM538325_500 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-07 | 183 | 77 | 6 | d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-07 | 184 | 77 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-07 | 184 | 77 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-07 | 184 | 77 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-07 | 187 | 77 | 6 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.39e-07 | 189 | 77 | 6 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-07 | 190 | 77 | 6 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.99e-07 | 191 | 77 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.09e-06 | 194 | 77 | 6 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-06 | 196 | 77 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-06 | 198 | 77 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-06 | 198 | 77 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-06 | 198 | 77 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-06 | 198 | 77 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.31e-06 | 200 | 77 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.31e-06 | 200 | 77 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.31e-06 | 200 | 77 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.31e-06 | 200 | 77 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.31e-06 | 200 | 77 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.31e-06 | 200 | 77 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.32e-06 | 145 | 77 | 5 | c0894c738815ff54790caddb4bccfa1503fd555b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.85e-06 | 161 | 77 | 5 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.96e-06 | 165 | 77 | 5 | 6a621b300442c52adfc15b61d3a6d3a3cb00099f | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.12e-05 | 169 | 77 | 5 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 169 | 77 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-05 | 181 | 77 | 5 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 181 | 77 | 5 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 182 | 77 | 5 | 751bd3e3b49de961523e98197688a05c998c121a | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-05 | 182 | 77 | 5 | 4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 184 | 77 | 5 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-05 | 184 | 77 | 5 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 185 | 77 | 5 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 186 | 77 | 5 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.87e-05 | 188 | 77 | 5 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 188 | 77 | 5 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-05 | 189 | 77 | 5 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.92e-05 | 189 | 77 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.97e-05 | 190 | 77 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.97e-05 | 190 | 77 | 5 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-05 | 190 | 77 | 5 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 191 | 77 | 5 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.17e-05 | 194 | 77 | 5 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-05 | 196 | 77 | 5 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 197 | 77 | 5 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 197 | 77 | 5 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 198 | 77 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.52e-05 | 200 | 77 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-05 | 200 | 77 | 5 | 979258173b82f37aeaaedd53b4a527da1dbe1b80 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.36e-05 | 133 | 77 | 4 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | P03-Hematopoietic-Erythroid|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-04 | 144 | 77 | 4 | 2ee6a834860eac7ed004f366ab4fc38c4b80c905 | |
| ToppCell | P03-Hematopoietic-Erythroid-enucleate_erythrocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-04 | 144 | 77 | 4 | 9fa63904389f4d7163db22ea85ab721d8f6e8d99 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.51e-04 | 155 | 77 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 156 | 77 | 4 | ea9223bb6450b22df11efa1705ab72dab005244a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 156 | 77 | 4 | 586b5509074c4cc359e9e31a968c2ded71c994ca | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 1.55e-04 | 156 | 77 | 4 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-04 | 158 | 77 | 4 | 1f94622186d8329357fa06785e03eeacf29ab1ce | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.70e-04 | 160 | 77 | 4 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 160 | 77 | 4 | 7064af50fc10e3ea03badf415306222b74db0f95 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-04 | 161 | 77 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-04 | 161 | 77 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 161 | 77 | 4 | 537a1d86de99a493b0345ca0f760994260e97049 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-04 | 161 | 77 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 161 | 77 | 4 | 7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 162 | 77 | 4 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-04 | 162 | 77 | 4 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 1.92e-04 | 165 | 77 | 4 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 1.92e-04 | 165 | 77 | 4 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 166 | 77 | 4 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 166 | 77 | 4 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-04 | 166 | 77 | 4 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 167 | 77 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-04 | 169 | 77 | 4 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-04 | 169 | 77 | 4 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 171 | 77 | 4 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-04 | 171 | 77 | 4 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-04 | 172 | 77 | 4 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.30e-04 | 173 | 77 | 4 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-04 | 173 | 77 | 4 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 2.40e-04 | 175 | 77 | 4 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.40e-04 | 175 | 77 | 4 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.45e-04 | 176 | 77 | 4 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-04 | 176 | 77 | 4 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-04 | 176 | 77 | 4 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.45e-04 | 176 | 77 | 4 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 2.45e-04 | 176 | 77 | 4 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 2.50e-04 | 177 | 77 | 4 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.50e-04 | 177 | 77 | 4 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.50e-04 | 177 | 77 | 4 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 177 | 77 | 4 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 177 | 77 | 4 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 178 | 77 | 4 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-04 | 179 | 77 | 4 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-NK_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 179 | 77 | 4 | 6f657c7a227f860934d0dfec9b97d35fd2cedfd2 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 2.61e-04 | 179 | 77 | 4 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.61e-04 | 179 | 77 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 179 | 77 | 4 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.61e-04 | 179 | 77 | 4 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 2.67e-04 | 180 | 77 | 4 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 2.67e-04 | 180 | 77 | 4 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| Computational | Neighborhood of ARL3 | 3.23e-05 | 304 | 45 | 8 | MORF_ARL3 | |
| Computational | Neighborhood of SUPT3H | 5.55e-05 | 328 | 45 | 8 | MORF_SUPT3H | |
| Computational | Neighborhood of RAD51L3 | 1.76e-04 | 387 | 45 | 8 | MORF_RAD51L3 | |
| Computational | Neighborhood of ERCC4 | 3.39e-04 | 321 | 45 | 7 | MORF_ERCC4 | |
| Drug | Zonisamide | 1.25e-11 | 17 | 75 | 6 | DB00909 | |
| Drug | lamotrigine | 1.11e-07 | 116 | 75 | 7 | CID000003878 | |
| Drug | flecainide | 1.26e-07 | 71 | 75 | 6 | CID000003355 | |
| Drug | Tetrodotoxin | 2.04e-07 | 40 | 75 | 5 | ctd:D013779 | |
| Drug | Sodium | 3.46e-07 | 84 | 75 | 6 | ctd:D012964 | |
| Drug | APETx1, Anthopleura elegantissima | 6.82e-07 | 6 | 75 | 3 | ctd:C475726 | |
| Drug | lidocaine | 9.86e-07 | 160 | 75 | 7 | CID000003676 | |
| Drug | tetradotoxin | SCN11A GUCY2F RBL2 SCN2A SCN3A SCN5A SCN8A SCN9A OPRD1 GABRA1 | 1.38e-06 | 428 | 75 | 10 | CID000020382 |
| Drug | gabapentin | 1.42e-06 | 169 | 75 | 7 | CID000003446 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.90e-06 | 8 | 75 | 3 | ctd:C489827 | |
| Drug | NSC7524 | 2.33e-06 | 182 | 75 | 7 | CID000005657 | |
| Drug | Ranolazine | 1.07e-05 | 2 | 75 | 2 | DB00243 | |
| Drug | Phenytoin | 1.07e-05 | 2 | 75 | 2 | DB00252 | |
| Drug | Procainamide | 1.07e-05 | 2 | 75 | 2 | DB01035 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.07e-05 | 2 | 75 | 2 | ctd:C005147 | |
| Drug | tetracaine | 1.07e-05 | 88 | 75 | 5 | CID000005411 | |
| Drug | potassium | ACSL1 GLS2 GUCY2F PDHB SCN2A SCN3A SCN5A SCN9A KCNIP1 ADCY9 RYR1 RYR3 GABRA1 | 2.30e-05 | 1008 | 75 | 13 | CID000000813 |
| Drug | riluzole | 2.38e-05 | 174 | 75 | 6 | CID000005070 | |
| Drug | Scorpion Venoms | 2.70e-05 | 18 | 75 | 3 | ctd:D012604 | |
| Drug | AC1L380G | 3.20e-05 | 19 | 75 | 3 | CID000084698 | |
| Drug | 2-hydroxycarbazole | 3.21e-05 | 3 | 75 | 2 | CID000093551 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 3.21e-05 | 3 | 75 | 2 | CID000080262 | |
| Drug | cis-diammineplatinum(II | 3.21e-05 | 3 | 75 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 3.21e-05 | 3 | 75 | 2 | CID002750949 | |
| Drug | flubendiamide | 3.21e-05 | 3 | 75 | 2 | CID011193251 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.21e-05 | 3 | 75 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 3.21e-05 | 3 | 75 | 2 | CID000127713 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 3.21e-05 | 3 | 75 | 2 | ctd:C561228 | |
| Drug | aminodantrolene | 3.21e-05 | 3 | 75 | 2 | CID009570289 | |
| Drug | isoflurane | 3.75e-05 | 279 | 75 | 7 | CID000003763 | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; PC3; HG-U133A | 4.25e-05 | 193 | 75 | 6 | 1957_DN | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A | 4.63e-05 | 196 | 75 | 6 | 4372_UP | |
| Drug | CGX 0596987; Up 200; 20uM; MCF7; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 6412_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.90e-05 | 198 | 75 | 6 | 4980_UP | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; PC3; HT_HG-U133A | 4.90e-05 | 198 | 75 | 6 | 6297_UP | |
| Drug | Dibucaine [85-79-0]; Up 200; 11.6uM; PC3; HT_HG-U133A | 5.04e-05 | 199 | 75 | 6 | 4068_UP | |
| Drug | mibefradil | 5.94e-05 | 64 | 75 | 4 | CID000060662 | |
| Drug | bepridil | 6.07e-05 | 126 | 75 | 5 | CID000002351 | |
| Drug | AC1L1CQC | 6.31e-05 | 65 | 75 | 4 | CID000002012 | |
| Drug | A-30 | 6.40e-05 | 4 | 75 | 2 | CID003028528 | |
| Drug | Lidocaine | 6.40e-05 | 4 | 75 | 2 | DB00281 | |
| Drug | PCB74 | 6.40e-05 | 4 | 75 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 6.40e-05 | 4 | 75 | 2 | CID006444275 | |
| Drug | Bastadin 10 | 6.40e-05 | 4 | 75 | 2 | CID009589366 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 6.40e-05 | 4 | 75 | 2 | ctd:C501880 | |
| Drug | SC 38249 | 6.40e-05 | 4 | 75 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 6.40e-05 | 4 | 75 | 2 | CID000035682 | |
| Drug | benzilate | 6.71e-05 | 66 | 75 | 4 | CID000201538 | |
| Drug | AC1L1IZE | 7.30e-05 | 131 | 75 | 5 | CID000004799 | |
| Drug | Kn 04 | 8.45e-05 | 26 | 75 | 3 | CID000131117 | |
| Drug | phenytoin | 8.57e-05 | 219 | 75 | 6 | CID000001775 | |
| Drug | AC1L1MOZ | 9.49e-05 | 27 | 75 | 3 | CID000031958 | |
| Drug | Topiramate | 1.06e-04 | 5 | 75 | 2 | DB00273 | |
| Drug | Quinidine barbiturate | 1.06e-04 | 5 | 75 | 2 | DB01346 | |
| Drug | 2,3-dimethylindoline | 1.06e-04 | 5 | 75 | 2 | CID000030944 | |
| Drug | LOPAC | 1.31e-04 | 30 | 75 | 3 | CID000062696 | |
| Drug | tocainide | 1.31e-04 | 30 | 75 | 3 | CID000038945 | |
| Drug | procaine | 1.52e-04 | 153 | 75 | 5 | CID000004914 | |
| Drug | fenpropathrin | 1.59e-04 | 6 | 75 | 2 | ctd:C044267 | |
| Drug | MBED | 1.59e-04 | 6 | 75 | 2 | CID000129958 | |
| Drug | chloro-m-cresol | 1.59e-04 | 6 | 75 | 2 | CID000012008 | |
| Drug | AC1O528X | 1.59e-04 | 6 | 75 | 2 | CID006475857 | |
| Drug | NSC114784 | 1.59e-04 | 6 | 75 | 2 | CID000419425 | |
| Drug | NSC692750 | 1.59e-04 | 6 | 75 | 2 | CID000078910 | |
| Drug | AC1LD8Z3 | 1.88e-04 | 86 | 75 | 4 | CID000644309 | |
| Drug | Amitriptyline | 2.16e-04 | 165 | 75 | 5 | ctd:D000639 | |
| Drug | Azumoleno | 2.22e-04 | 7 | 75 | 2 | CID000056259 | |
| Drug | mag-indo-1 | 2.22e-04 | 7 | 75 | 2 | CID000131881 | |
| Drug | Br2BAPTA | 2.22e-04 | 7 | 75 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.22e-04 | 7 | 75 | 2 | CID009547999 | |
| Drug | CHEBI:564108 | 2.22e-04 | 7 | 75 | 2 | CID006400637 | |
| Drug | gallocyanin | 2.22e-04 | 7 | 75 | 2 | CID000073801 | |
| Drug | benzocaine | 2.46e-04 | 37 | 75 | 3 | CID000002337 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 2.46e-04 | 37 | 75 | 3 | CID000009643 | |
| Drug | 4-chloro-m-cresol | 2.46e-04 | 37 | 75 | 3 | CID000001732 | |
| Drug | sodium | SCN2A SCN3A SCN5A SCN9A CHN1 ADCY9 RYR1 RYR3 OPRD1 DNMT1 GABRA1 | 2.54e-04 | 944 | 75 | 11 | CID000000923 |
| Drug | N-arachidonoyl-dopamine | 2.88e-04 | 39 | 75 | 3 | CID005282105 | |
| Drug | 5-butyl-2-phenoxyphenol | 2.96e-04 | 8 | 75 | 2 | CID005274975 | |
| Drug | Cocaine | 2.96e-04 | 8 | 75 | 2 | DB00907 | |
| Drug | carbamazepine | 3.14e-04 | 179 | 75 | 5 | CID000002554 | |
| Drug | AC1L1I54 | 3.34e-04 | 41 | 75 | 3 | CID000004426 | |
| Drug | isradipine | 3.35e-04 | 100 | 75 | 4 | CID000003784 | |
| Drug | isoproterenol | 3.45e-04 | 669 | 75 | 9 | CID000003779 | |
| Drug | Mycophenolic acid [24280-93-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.66e-04 | 185 | 75 | 5 | 4137_UP | |
| Drug | lactosyl lysosphingolipid | 3.80e-04 | 9 | 75 | 2 | CID006439268 | |
| Drug | AC1Q7A0V | 3.80e-04 | 9 | 75 | 2 | CID000001250 | |
| Drug | m-7a | 3.80e-04 | 9 | 75 | 2 | CID000029558 | |
| Drug | Mexiletine | 3.80e-04 | 9 | 75 | 2 | ctd:D008801 | |
| Drug | ApApA | 3.80e-04 | 9 | 75 | 2 | CID000097495 | |
| Drug | FLA 365 | 3.80e-04 | 9 | 75 | 2 | CID000072776 | |
| Drug | Gossypol [303-45-7]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.93e-04 | 188 | 75 | 5 | 4296_UP | |
| Drug | procainamide | 4.13e-04 | 190 | 75 | 5 | CID000004913 | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; HL60; HG-U133A | 4.13e-04 | 190 | 75 | 5 | 1372_UP | |
| Drug | propofol | 4.23e-04 | 191 | 75 | 5 | CID000004943 | |
| Drug | baclofen | 4.23e-04 | 191 | 75 | 5 | CID000002284 | |
| Drug | phosphine oxide | 4.34e-04 | 107 | 75 | 4 | CID000166931 | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; HL60; HT_HG-U133A | 4.44e-04 | 193 | 75 | 5 | 2346_UP | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.54e-04 | 194 | 75 | 5 | 4182_UP | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 4.54e-04 | 194 | 75 | 5 | 4107_DN | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.54e-04 | 194 | 75 | 5 | 4015_UP | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.75e-17 | 10 | 76 | 7 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.75e-17 | 10 | 76 | 7 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 4.44e-16 | 12 | 76 | 7 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.00e-08 | 163 | 76 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.85e-08 | 13 | 76 | 4 | C0751122 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.87e-07 | 22 | 76 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 5.70e-07 | 7 | 76 | 3 | C0020075 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.36e-06 | 9 | 76 | 3 | C3502809 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 6.55e-06 | 2 | 76 | 2 | C4551549 | |
| Disease | Epilepsy | 9.40e-06 | 109 | 76 | 5 | C0014544 | |
| Disease | B Virus Infection | 1.96e-05 | 3 | 76 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 1.96e-05 | 3 | 76 | 2 | cv:C5575231 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.96e-05 | 3 | 76 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Postherpetic neuralgia | 1.96e-05 | 3 | 76 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 1.96e-05 | 3 | 76 | 2 | C0019372 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.96e-05 | 3 | 76 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 1.96e-05 | 3 | 76 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 1.96e-05 | 3 | 76 | 2 | C0014805 | |
| Disease | Epilepsy, Cryptogenic | 6.10e-05 | 82 | 76 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 6.10e-05 | 82 | 76 | 4 | C0751111 | |
| Disease | Aura | 6.10e-05 | 82 | 76 | 4 | C0236018 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 2 | 6.51e-05 | 5 | 76 | 2 | C0020072 | |
| Disease | Familial benign neonatal epilepsy | 9.75e-05 | 6 | 76 | 2 | C0220669 | |
| Disease | Sensory Neuropathy, Hereditary | 9.75e-05 | 6 | 76 | 2 | C0699739 | |
| Disease | Neurodevelopmental Disorders | 9.97e-05 | 93 | 76 | 4 | C1535926 | |
| Disease | Seizure, Febrile, Simple | 1.36e-04 | 7 | 76 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 1.36e-04 | 7 | 76 | 2 | C0751057 | |
| Disease | Congenital Pain Insensitivity | 1.36e-04 | 7 | 76 | 2 | C0002768 | |
| Disease | N-palmitoylglycine measurement | 1.36e-04 | 7 | 76 | 2 | EFO_0800342 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 1.81e-04 | 8 | 76 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 1.81e-04 | 8 | 76 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 1.81e-04 | 8 | 76 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 1.81e-04 | 8 | 76 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 1.81e-04 | 8 | 76 | 2 | C0751120 | |
| Disease | Myoclonic Absence Epilepsy | 1.81e-04 | 8 | 76 | 2 | C0393703 | |
| Disease | Drug habituation | 2.26e-04 | 115 | 76 | 4 | C0013170 | |
| Disease | Substance-Related Disorders | 2.26e-04 | 115 | 76 | 4 | C0236969 | |
| Disease | Drug abuse | 2.26e-04 | 115 | 76 | 4 | C0013146 | |
| Disease | Drug Use Disorders | 2.26e-04 | 115 | 76 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.26e-04 | 115 | 76 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.26e-04 | 115 | 76 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.26e-04 | 115 | 76 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.26e-04 | 115 | 76 | 4 | C0029231 | |
| Disease | Prescription Drug Abuse | 2.26e-04 | 115 | 76 | 4 | C4316881 | |
| Disease | Febrile Convulsions | 2.33e-04 | 9 | 76 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 2.33e-04 | 9 | 76 | 2 | C0014550 | |
| Disease | Substance abuse problem | 2.34e-04 | 116 | 76 | 4 | C0740858 | |
| Disease | Epilepsy, Myoclonic, Infantile | 2.91e-04 | 10 | 76 | 2 | C0917800 | |
| Disease | Myoclonic Astatic Epilepsy | 3.55e-04 | 11 | 76 | 2 | C0393702 | |
| Disease | adverse effect, response to xenobiotic stimulus | 4.81e-04 | 59 | 76 | 3 | EFO_0009658, GO_0009410 | |
| Disease | infant head circumference | 6.73e-04 | 15 | 76 | 2 | EFO_0004577 | |
| Disease | MMR-related febrile seizures | 6.73e-04 | 15 | 76 | 2 | EFO_0006519 | |
| Disease | Tremor, Rubral | 7.67e-04 | 16 | 76 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 7.67e-04 | 16 | 76 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 7.67e-04 | 16 | 76 | 2 | C0278161 | |
| Disease | Abnormal coordination | 7.67e-04 | 16 | 76 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 7.67e-04 | 16 | 76 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 7.67e-04 | 16 | 76 | 2 | C0240991 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 7.67e-04 | 16 | 76 | 2 | C0393706 | |
| Disease | partial epilepsy | 8.68e-04 | 17 | 76 | 2 | EFO_0004263 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 9.75e-04 | 18 | 76 | 2 | HP_0002373 | |
| Disease | systemic lupus erythematosus | 1.04e-03 | 799 | 76 | 8 | MONDO_0007915 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.17e-03 | 80 | 76 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | BRCAX breast cancer | 1.21e-03 | 20 | 76 | 2 | EFO_0009443 | |
| Disease | birth weight, parental genotype effect measurement | 1.55e-03 | 192 | 76 | 4 | EFO_0004344, EFO_0005939 | |
| Disease | airway responsiveness measurement | 1.74e-03 | 24 | 76 | 2 | EFO_0006897 | |
| Disease | Ataxia | 1.89e-03 | 25 | 76 | 2 | C0004134 | |
| Disease | retinal vasculature measurement | 2.18e-03 | 517 | 76 | 6 | EFO_0010554 | |
| Disease | cardiovascular age measurement | 2.54e-03 | 29 | 76 | 2 | EFO_0803380 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EMRVRCAIIPSDMLH | 226 | Q8N9N5 | |
| CILMRNHDVTEQPMV | 256 | P51689 | |
| DMSALVAARMRHIPL | 1416 | P26358 | |
| EPRVRLVMAQHMIRD | 161 | P46379 | |
| PLAHMFERVVECVML | 321 | P33121 | |
| CAIHARRVTIMPRDM | 111 | P0DPK5 | |
| LETCRIMIAMLDRDH | 91 | P28676 | |
| SPTIRDMAIRCIAQM | 1196 | Q9Y6D5 | |
| NPEMCRVLLTHEVMC | 146 | Q9HAK2 | |
| LTMMAVCHTAVPERE | 481 | Q9Y2Q0 | |
| VISSMPCLLMELRRD | 51 | Q96B23 | |
| SFPILLHMMCSERDR | 1351 | Q14571 | |
| PITVRHIESMIRMAE | 761 | P49736 | |
| IIQCPELMMDRHLDQ | 876 | Q08999 | |
| VECEVINMRTIRPMD | 261 | P11177 | |
| DMPAVMRLACADTRV | 181 | Q8NGI7 | |
| LLDRRPTECMMSRSV | 531 | Q5VUB5 | |
| PTECMMSRSVDHLER | 536 | Q5VUB5 | |
| PRMMQDADCHRLLVD | 276 | Q9H511 | |
| MSRHPRVCGAVMDTL | 256 | P13196 | |
| ISSLVQLMMDPHCRT | 401 | Q9C0I1 | |
| RVLLEQMGSLPCAMH | 841 | Q9BY66 | |
| LCVILEPMQELMSRH | 206 | O43679 | |
| LVRHSDMPEEMRVET | 21 | O96015 | |
| CAIHARRVTIMPRDM | 111 | P0DPK2 | |
| HFLREMPALIRMACV | 176 | Q7Z3T1 | |
| IHLCQMRMCTQPDLV | 231 | O75037 | |
| SVVPARMAEMARCIR | 231 | P53602 | |
| MMVHCAGCERPILDR | 1 | Q9H2C1 | |
| YTMRLTVRAECPMHL | 156 | P14867 | |
| PRLRDCMSEMHRVVQ | 106 | Q9UI32 | |
| HIVLMLADDMACNPR | 81 | Q92643 | |
| DELEMTMVCHRPEGL | 36 | Q9NZI2 | |
| CDSLCIPMVMRHLEQ | 551 | Q5TIA1 | |
| MAVTRPRDGAVVCML | 186 | P41143 | |
| RVAPEQQMIADIHCM | 201 | Q96T49 | |
| TIHDIRCSVMMIRTP | 616 | Q9UI47 | |
| RCSVMMIRTPEELED | 621 | Q9UI47 | |
| HMVLCMSPIGEVFRA | 2711 | Q9P2D7 | |
| DRTEMPCQALVRMLA | 631 | Q14008 | |
| TQHDCREILLPMMTD | 851 | Q14185 | |
| PDVVMRERLAMCTNL | 96 | Q8NFW5 | |
| IHQADRIRIIIMCMH | 236 | P51841 | |
| RDDFLFVIEHMMPLC | 696 | Q9BZC7 | |
| ERMIHSVMPRIIADD | 331 | O60503 | |
| PSCLHDSMEMLRLED | 201 | Q5SZL2 | |
| CLRFMREVERLMTPE | 561 | O00519 | |
| TALQRLCMLRAMRPD | 3846 | Q9NYC9 | |
| PLHRCNIAVIFMTEM | 1636 | Q5TBA9 | |
| AHTTKRPMVVDMCIR | 276 | P15882 | |
| RPMVVDMCIREIESR | 281 | P15882 | |
| MALHIPEENRCMDIL | 1636 | P21817 | |
| RQMRSVDVTLMPIDC | 51 | P07358 | |
| GIRSDVCQHAMMLPV | 851 | Q9NRR4 | |
| MITHALERVCSVMPA | 316 | Q6NUJ1 | |
| NCRMLMKTPHDILED | 196 | Q9Y6Q9 | |
| PMVSGDRIHCMDILF | 1841 | Q14524 | |
| MDLPMVSGDRIHCLD | 1826 | Q15858 | |
| MSRALADVMRPQGHC | 186 | B4DS77 | |
| AMDLPMVSGDRIHCL | 1836 | Q9NY46 | |
| AMDLPMVSGDRIHCL | 1851 | P35498 | |
| MMALLCAPVRDEAVQ | 166 | Q8WWU5 | |
| PMDAAQREEHMRACI | 276 | Q13064 | |
| MMALHIPEENRCVDI | 1531 | Q15413 | |
| AMDLPMVSGDRIHCL | 1841 | Q99250 | |
| AAIMHPGVVCIMVRL | 826 | Q6ZS81 | |
| AMDLPMVSGDRIHCL | 1831 | Q9UQD0 | |
| LMICQRRSPAMHRTC | 16 | Q6UXP9 | |
| AAMMAVRVLLDHDVP | 461 | Q9NWZ5 | |
| VMQCSHLVMRPVALD | 591 | Q8N1G0 | |
| PTTIMNCRRMHTVIA | 1076 | O60346 | |
| DLPMVSEDRLHCMDI | 1671 | Q9UI33 | |
| RRIEMEDPCLMLASR | 206 | A2RU30 | |
| LDRHEQICMRSSHMP | 386 | Q8NAP3 | |
| TMMELRCVIAVIRHG | 376 | O43314 | |
| SLQHLCRMSIRRVMP | 386 | Q9Y6I7 | |
| PVAARATHRVHMEVM | 1136 | P48553 | |
| MRVPSALVTLHMLLC | 1031 | Q69YN4 | |
| GTMMELRCVIAIIRH | 386 | Q6PFW1 | |
| LAMTLDRHRAICRPM | 131 | P30518 | |
| AVEVMCIVPRRCNDM | 2131 | O75962 | |
| DIICDVGMPVMHRNV | 81 | Q6IA69 |